In our case, however, more than 80% of the samples that acquired 3p-loss (that overlapped BAP1 and PBRM1) without 22q-loss were grade I (Supplementary Data 5), extending a role for this driver to a broader spectrum of meningiomas that includes low grade lesions. This evidence concerns the gene PBRM1 and meningioma.